Overview A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy Status: Completed Trial end date: 2007-03-01 Target enrollment: Participant gender: Summary A study for the treatment of hormone refractory prostate cancer (HRPC) in patients previously treated with chemotherapy. Phase: Phase 2 Details Lead Sponsor: Astellas Pharma IncCollaborator: Astellas Pharma US, Inc.